Completed
ORIENT: Olmesartan Reducing Incidence of End Stage Renal Disease in Diabetic Nephropathy Trial
NCT00141453
- Conditions
- Chronic Disease, Diabetes Complications, Diabetes Mellitus, +24 more
- Locations
-
- Hong Kong, China
- Tokyo, Japan